Detalles de la búsqueda
1.
Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer.
Ther Adv Med Oncol;
16: 17588359231217959, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38249330
2.
A Rare Case of Hereditary Hemochromatosis Presenting With Porphyria Cutanea Tarda.
Cureus;
15(7): e41299, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37539416
3.
Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature.
Ther Adv Med Oncol;
15: 17588359231193722, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37667781
4.
Oculomotor Nerve Palsy as a Manifestation of Immune Thrombocytopenic Purpura: A Case Report.
Cureus;
14(9): e29723, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36320952
5.
Serendipitous synergism - an exceptional response to treatment with pembrolizumab in the course of a natural immunovirotherapy: a case report and review of the literature.
Ther Adv Med Oncol;
14: 17588359221122729, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36312814
Resultados
1 -
5
de 5
1
Próxima >
>>